Actively Recruiting
Evaluation of the Symani Surgical System for Robotic-Assisted Microsurgery in Mild to Moderate Alzheimers Disease Patients with Lymphatic Abnormalities
Led by MMI (Medical Microinstruments, Inc.) · Updated on 2026-08-24
15
Participants Needed
3
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the safety and feasibility of using the Symani Surgical System, a robotic-assisted device, to perform microsurgical techniques in the deep cervical lymph node dCLN area of patients with mild to moderate Alzheimers disease who also have lymphatic abnormalities. This early feasibility study aims to improve the clearance of neurotoxins such as amyloid-beta and phosphorylated tau, which are linked to Alzheimers disease, by targeting lymphatic drainage in the head and neck region. Participants will undergo a procedure using the Symani System to perform microsurgery in the dCLN region. The study focuses on assessing device-related serious adverse events within 30 days after the procedure, along with longer-term safety and effectiveness measures at 6 months. Outcomes include the rate of adverse events, reoperation rates, changes in amyloid PET imaging, plasma biomarkers, and surgical success measures such as anastomosis patency. Throughout the study, participants will have pre-procedure visits, the surgical procedure itself, and follow-up assessments including imaging and blood tests to monitor changes in disease markers and safety outcomes. The main safety evaluation occurs at 30 days post-procedure, with additional assessments extending to 6 months. Participants will be followed for device-related complications, biomarker changes, and overall health status during the trial period.
CONDITIONS
Brief Title
Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease
Research Team
C
Clinical Operations
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here